CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects
Condition(s):Health, SubjectiveLast Updated:July 26, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Health, SubjectiveLast Updated:July 26, 2019Completed
Condition(s):Cutaneous VasculitisLast Updated:December 2, 2015Unknown status
Condition(s):Ulcerative Colitis (UC)Last Updated:August 1, 2023Completed
Condition(s):Ulcerative Colitis (UC)Last Updated:October 12, 2023Active, not recruiting
Condition(s):InfluenzaLast Updated:September 6, 2012Completed
Condition(s):Covid19; Cytokine Release Syndrome; Critical Illness; ARDSLast Updated:July 30, 2020Completed
Condition(s):AllergyLast Updated:November 22, 2012Completed
Condition(s):Ankylosing SpondylitisLast Updated:April 29, 2022Completed
Condition(s):Food HypersensitivityLast Updated:June 5, 2019Unknown status
Condition(s):Generalized Myasthenia GravisLast Updated:January 11, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.